Therapeutic Effect of Oncolytic Herpes Simplex Virus on Induced Radioresistant Head and Neck Squamous Cell Carcinoma
![]() |
Kim, Se-Heon
(Department of Otorhinolaryngology, Yonsei University College of Medicine)
Choi, Eun-Chang (Department of Otorhinolaryngology, Yonsei University College of Medicine) Lee, Jin-Seok (Department of Otorhinolaryngology, Yonsei University College of Medicine) Chun, Je-Young (Department of Otorhinolaryngology, Yonsei University College of Medicine) Byun, Hyung-Kwon (Department of Otorhinolaryngology, Yonsei University College of Medicine) Song, Ki-Jae (Department of Otorhinolaryngology, Yonsei University College of Medicine) Kim, Kwang-Moon (Department of Otorhinolaryngology, Yonsei University College of Medicine) |
1 | Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Med. 1995;1:938-943 DOI |
2 | Kooby DA, Carew JF, Halterman MW, et al: Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herped simplex virus type-1 (G207 ). FASEB. 1999;13:1325-1334 DOI |
3 | Schang LM, Philips J, Schaffer PA: Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol. 1998;72 (7 ):5626-5637 |
4 | Girinsky T, Lubin R, Pignon JP, Chavaudra N, Gazeau J, Dubray B: Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 1993;25:147-148 DOI ScienceOn |
5 | Kim SH, Carew JF, Kooby DA, et al: Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Ther. 2000;7:1279-1285 DOI ScienceOn |
6 | Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y: Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207 ). Hum Gene Ther. 1999;10:1599-1606 DOI ScienceOn |
7 | West CM, Davidson SE, Roberts SA, Hunter RD: Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 1993;68:819-823 DOI ScienceOn |
8 | Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier JW, Hars Vl: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N. Engl J Med. 1998;338:1798-1804 DOI ScienceOn |
9 | Kim SH, Wong RJ, Kooby DA, et al: Combination of mutated herpes simplex virus type 1 (G207 virus ) with radiation for the treatment of squamous cell carcinoma of the head and neck. Eur J Cancer. 2005;41 (2 ):313-322 DOI ScienceOn |
10 | Lambin P, Malaise EP, Joiner MC: Might intrinsic radioresistance of human tumour cells be induced by radiation? Int J Radiat Biol. 1996;69 (3 ):279-290 DOI |
11 | Wong RJ, Joe JK, Kim SH, Shah JP, Horsburgh B, Fong Y: Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther. 2002;13:1213-1223 DOI ScienceOn |
12 | Pearce AG, Segura TM, Rintala AC, Rintala-Maki ND, Lee H: The generation and characterization of a radiation-resistant model system to study radioresistance in human breast cancer cells. Radiate Res. 2001;156 (6 ):739-750 DOI ScienceOn |
13 | Falck J, Petrini JH, Williams BR, Lukas J, Bartek J: The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Gen. 2002;30:290-294 DOI ScienceOn |
14 | Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y: Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. J Am Coll Surg. 2001;193:12-21 DOI ScienceOn |
![]() |